R2 Technologies - Our Story

In 2014, R2 secured the exclusive license from Blossom Innovations, LLC and Massachusetts General Hospital to develop a technology based on their patented method of pausing melanin production.  Since that time, R2 has conducted the design, development and extensive clinical research necessary to bring our first product to market.

down-arrow

Timeline

2014

The Founding of R2

Pansend Life Sciences, LLC and Blossom Innovations, LLC founded R2 Technologies and licensed exclusive intellectual property from Massachusetts General Hospital and Blossom Innovations on their patented method of pausing melanin.

Research

R2 begins the research and development of the technology around Cryomodulation.

2015
2016

FDA Clearance

R2 receives clearance for the removal of benign lesions of the skin.

FDA Clearance

R2 receives clearance for their next-generation system.

2017
2018

First Published Manuscript from founders

Lasers in Surgery and Medicine introduces the treatment of benign lesions utilizing a novel dermal cooling system.

Strategic Partnership

R2 closes strategic investment and commercial partnership with Huadong Medicine Co., Ltd.

2019
2020

FDA Clearance

R2 receives expanded indication for the temporary reduction of pain, swelling and inflammation.

Glacial Rx® and Glacial Spa®
treatments available

First commercial installations and treatments underway in select countries.

2021

Scientific Founders

R. ROX ANDERSON, M.D.

R. ROX ANDERSON, M.D.

DIETER MANSTEIN, M.D., PH.D.

DIETER MANSTEIN, M.D., PH.D.

HENRY H. L. CHAN, M.D., PH.D.

HENRY H. L. CHAN, M.D., PH.D.

R2 Team

Tim Holt is President and CEO of R2 Technologies, headquar-tered in San Ramon, California. R2 is currently developing breakthrough CryoAesthetic technologies that will launch in the US and China markets in early 2021. Tim has 17 years of commercial experience in the aesthetic medical device industry which includes key leadership roles at Reliant Technologies and ZELTIQ. He was at the forefront of the successful product launches of Fraxel and CoolSculpting as well as the growth and scaling of those two ventures from start-up to IPO/acquisition. R2 will be Tim’s third successive company delivering a
game-changing product to market that originated in the labs of world-renowned serial inventors, Drs. Rox Anderson, Dieter Manstein and Henry Chan.

Tim is a native of Ohio. He received his BBA in Marketing from Ohio University in 1997 and his MBA from Campbell University in 1999. He has been involved in various youth mentorship and philanthropic organizations. He is a member of the Ohio University Executive Advisory Board, he’s a sponsor of the Ohio University Select Leaders Program and he’s an Ambassador for the Gratitude Network.

TIM HOLT

TIM HOLT

President & CEO

Kristine has dedicated her 25-year career to cryobiology research and the development of cold-based medical devices. She held a leadership position at ZELTIQ and dedicated the last decade to aesthetic applications for cold therapies.

KRISTINE TATSUTANI

KRISTINE TATSUTANI

Chief Science & Technology Officer

Mike has 20 years of experience helping healthcare companies bring innovative technologies to market. Mike’s career began at Johnson & Johnson in operations and commercial roles. More recently, he held commercial roles at Biolux Research, Elira, and ZELTIQ.

MIKE LAMBERSON

MIKE LAMBERSON

Senior Vice President of Marketing

Pete comes to R2 with over 20 years of sales leadership experience in aesthetic device, dental, and software technology. He led the Southeast US teams at Thermage and Solta Medical to award winning performances with brands such as Thermage, Fraxel, Isolaz, and Clear + Brilliant.

As the General Manager for distributors Patterson Dental and Benco Dental, he led business units up to $50M in annual sales revenues.

Most recently, Pete led the US sales efforts at startup fintech provider HintMD, growing the business from zero to over $250M in annual processing sales. HintMD was successfully acquired by Revance Aesthetics in July 2020.

PETE COUSINS

PETE COUSINS

Senior Vice President of North America Sales

Roger has been in the pharmaceutical/medical device industry for over 20 years. He jumped into aesthetic medicine in 2012 with ZELTIQ, assuming the role as Managing Director of APAC for CoolSculpting. He then moved on to miraDry where he built and managed the APAC, Middle East and LATAM business.

ROGER SCHMID

ROGER SCHMID

Vice President of International Business

Casey has 20+ years’ experience leading high performing teams in sales operations, customer service, and logistics in the medical aesthetics and life science industries. Most recently with ZELTIQ where he helped to launch the CoolSculpting brand and commercial programs.

CASEY TORREZ

CASEY TORREZ

Vice President of Operations

For the last 20 years, Ragan has worked in the high-tech and medtech industry. She has been instrumental in multiple stages of the IPO process, most recently with ZELTIQ.

RAGAN REPPOND

RAGAN REPPOND

Vice President of Corporate Affairs and Compliance

Angell is a CPA and FP&A with 20 years of both public and private company experience. She brings a wide breadth of accounting and finance knowledge.

ANGELL HAIFLICH

ANGELL HAIFLICH

Corporate Controller

Board of Directors

David A. Present, MD, Chairman, Founder, and General Partner, Pansend Life Sciences, LLC

Cherine Eldumiati Plumaker, Vice Chairman, Founder, and General Partner, Pansend Life Sciences, LLC

Irina Erenburg, PHD, Chief Executive Officer, Blossom Innovations, LLC

Yuhang Zhao, PHD, MBA, Adviser to China Grand, Inc.

Seth Orlow, MD, PHD, Professor and Chair of Dermatology, NYU School of Medicine

Tim Holt, MBA, PRESIDENT AND CEO, R2 Technologies, Inc.

Exclusive Partners

Allies of Skin

Founded in 2016 by Nicolas Travis, a Forbes “30 Under 30,” and sold in more than 29 markets worldwide and counting, cult-favorite brand Allies of Skin creates multi-benefit formulas for all skin types that work harder and smarter. Each multitasking product takes clinically proven actives and combines them with innovative, optimally concentrated, biocompatible ingredients that work synergistically to provide maximum results. Allies of Skin’s clinical-grade formulas are clean and effective, smart and sophisticated, and packed with the greatest amount of active ingredients possible, winning numerous prestigious beauty awards from magazines including Allure, Harper’s Bazaar, Teen Vogue and InStyle.

Huadong Medicine Company, Limited

Huadong Medicine Co., Ltd., is a leading Chinese pharmaceutical company based in Hangzhou, China. Founded in 1993, Huadong Medicine has fully integrated R&D, manufacturing, distribution, sales and marketing capabilities. Huadong Medicine’s product portfolio and pipeline are specialized in oncology, immunology, nephrology and diabetes. The company’s annual revenue in 2019 exceeded 5 billion USD. Huadong Medicine has 12,000 employees, among which 1,000 are dedicated to R&D. Huadong Medicine possesses one of the most extensive commercial coverage and marketing capabilities in China. Huadong Medicine Company – Patient Centered, Science Driven.

Contact us

2603 Camino Ramon, Suite 200, Bishop Ranch 3,
San Ramon, CA 94583
Email ‒ info@r2technologies.com
Call ‒ (925) 378-4400